Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma.
Bahamondes
Luis
L
Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas, Campinas, SP, Brazil. bahamonde@caism.unicamp.br
Ribeiro-Huguet
Priscila
P
de Andrade
Kleber Cursino
KC
Leon-Martins
Omar
O
Petta
Carlos A
CA
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D003692:Delayed-Action Preparations; D004714:Endometrial Hyperplasia / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage* / Q000494:pharmacology*; D008875:Middle Aged; D045167:Progesterone Congeners / Q000008:administration & dosage* / Q000494:pharmacology*; D016896:Treatment Outcome
D003692:Delayed-Action Preparations; D045167:Progesterone Congeners; D016912:Levonorgestrel